Saudi Arabia Pharmaceutical Market Sales Revenue Opportunity Report

The Saudi Arabia Pharmaceutical market has recorded significant growth over the years driven by various factors like increasing ageing population mostly in the above 60 years bracket, changing demographics and rise in the incidence of lifestyle diseases, increased spending power, result driven government initiatives to promote the growth of indigenous pharmaceutical companies. Inspite of the progress, the pharmaceutical sector in the Saudi Arabia is still in an emerging phase, and drug manufacturing is at a relatively nascent stage owing to many challenges, which need to be resolved. The Saudi pharmaceuticals market has accounted for more than to 50% of all pharmaceutical products sales in the GCC region.

Download Report:

https://www.kuickresearch.com/report-Saudi-Arabia-Pharmaceutical-Market-Development-Analysis.php

For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990

"Saudi Arabia Pharmaceutical Market Development Analysis" Table of Contents

1. Saudi Arabia Pharmaceutical Market Overview
1.1 Current Market Scenario
1.2 Disease Prevalence

2. Pharmaceutical Market by Segment
2.1 Branded Drugs
2.2 Generic drugs
2.3 OTC

3. Saudi Arabia Drug Pricing System

4. Saudi Arabia Pharmaceutical Market Dynamics
4.1 Market Dominance in Middle East
4.2 Support to Domestic Pharmaceutical Industry
4.3 Favorable & Established Regulatory Framework
4.4 Preference for OTC & Generics Drugs
4.5 Import Dependent Market
4.6 Challenges to be Resolved

5. Saudi Arabia Pharmaceutical Market Future Outlook

6. Key Regulatory Enforcement Departments
6.1 National Drug and Poison Information Center
6.2 National Pharmacovigilance Center
6.3 Licensing Directorate
6.4 Executive Directorate of Laboratories
6.5 Executive Directorate of Inspection and Law Enforcement
6.6 Executive Directorate of Product Evaluation & Standard Setting


7. Pharmaceutical Market Regulatory Framework
7.1 Drug Approval Process (Generics, Biologicals, Radipharmaceuticals & New Chemical Entity)
7.2 Monoclonal Antibodies and Related Products Quality Guideline
7.3 Law of Pharmaceutical Establishments and Preparations
7.4 Guidelines on Biosimilars
7.4.1 Insulin
7.4.2 Interferons
7.4.3 Erythropoietin
7.4.4 Granulocyte-Colony Stimulating Factor
7.4.5 Human Growth Hormone
7.5 Priority Review of Product Registration
7.6 Drug Barcoding Specifications

8. Competitive Landscape
8.1 SPIMACO
8.2 Tabuk Pharmaceuticals
8.3 Jamjoom Pharma
8.4 Julphar (Gulf Pharmaceutical Industries)
8.5 GSK
8.6 Pfizer
8.7 Novartis
8.8 Astra

Figure 1-1: Saudi Arabia Pharmaceutical Market (US$ Billion), 2013-2018
Figure 1-2: Saudi Arabia Pharmaceutical Market by Segment (US$ Billion), 2013-2018
Figure 1-3: Saudi Arabia Pharmaceutical Market by Segment (%), 2013 & 2018
Figure 1-4: Factors Driving Growth in Saudi Pharmaceuticals Market
Figure 1-5: Burden of Communicable & Non Communicable Diseases in Saudi Arabia, 2012 & 2030
Figure 1-6: Leading Causes of Death in Saudi Arabia, 2011

Figure 2-1: Saudi Arabian Branded Drugs Market Value (US$ Billion), 2013-2018
Figure 2-2: Saudi Arabian Generics Drug Market Value (US$ Billion), 2013-2018
Figure 2-3: Saudi Arabian OTC Drug Market (US$ Billion), 2013-2018

Figure 3-1: Components of Drug Pricing System in Saudi Arabia

Figure 4-1: Share of Saudi Arabia in GCC Pharmaceuticals Market, 2013
Figure 4-2: Government Healthcare Expenditure (US$ Billion), 2012 & 2013

Figure 7-1: Saudi Arabia Drug Approval Process
Figure 7-2: Process for Designating A Drug For The Priority Review
Figure 7-3: Drug Barcoding Standard
Figure 7-4: Drug Barcoding Sample

List of Tables

Table 3-1: Pricing History and Legal Background in Saudi Arabia
Table 3-2: Drug Pricing for Generics
Table 3-3: Drug Pricing for Fixed Combinations

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
Avanta Business Center 4th Floor,
Statesman House Barakhamba Road,
Connaught Place New Delhi – 110 001, India
+91-11-47067990

This release was published on openPR.